the efficacy in cancer treatment of monoclonal antibodies or other macromolecules bound to radionuclides , chemotherapeutic agents , toxins , enzymes , growth factors , or effector antibodies has been limited by their inability to reach their target in vivo in adequate quantities .
C0003250
monoclonal antibodies
C0003241
antibodies